Virus-like particles in vaccine development

Research output: Book/ReportBook

Abstract

Alternative strategies to vaccines based on live attenuated or inactivated pathogens are constantly being developed with an aim to increase safety without significant loss of immunogenicity. Among these, virus-like particles (VLPs) offer several valuable features and represent a very appealing model. The eight timely and in-depth chapters of this book have been contributed by leaders in the field and cover a range of current topics in VLP-based vaccine development and clinical assessment for a range of human infectious diseases.

Original languageEnglish
PublisherFuture Medicine Ltd.
Number of pages136
ISBN (Print)9781780844176, 9781780844190
DOIs
Publication statusPublished - Jan 1 2014

Fingerprint

Virus-Like Particle Vaccines
Virion
Communicable Diseases
Vaccines
Safety

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Virus-like particles in vaccine development. / Buonaguro, Franco M.; Buonaguro, Luigi.

Future Medicine Ltd., 2014. 136 p.

Research output: Book/ReportBook

@book{4430f742ec454d348adb658966373b7d,
title = "Virus-like particles in vaccine development",
abstract = "Alternative strategies to vaccines based on live attenuated or inactivated pathogens are constantly being developed with an aim to increase safety without significant loss of immunogenicity. Among these, virus-like particles (VLPs) offer several valuable features and represent a very appealing model. The eight timely and in-depth chapters of this book have been contributed by leaders in the field and cover a range of current topics in VLP-based vaccine development and clinical assessment for a range of human infectious diseases.",
author = "Buonaguro, {Franco M.} and Luigi Buonaguro",
year = "2014",
month = "1",
day = "1",
doi = "10.2217/9781780844176",
language = "English",
isbn = "9781780844176",
publisher = "Future Medicine Ltd.",

}

TY - BOOK

T1 - Virus-like particles in vaccine development

AU - Buonaguro, Franco M.

AU - Buonaguro, Luigi

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Alternative strategies to vaccines based on live attenuated or inactivated pathogens are constantly being developed with an aim to increase safety without significant loss of immunogenicity. Among these, virus-like particles (VLPs) offer several valuable features and represent a very appealing model. The eight timely and in-depth chapters of this book have been contributed by leaders in the field and cover a range of current topics in VLP-based vaccine development and clinical assessment for a range of human infectious diseases.

AB - Alternative strategies to vaccines based on live attenuated or inactivated pathogens are constantly being developed with an aim to increase safety without significant loss of immunogenicity. Among these, virus-like particles (VLPs) offer several valuable features and represent a very appealing model. The eight timely and in-depth chapters of this book have been contributed by leaders in the field and cover a range of current topics in VLP-based vaccine development and clinical assessment for a range of human infectious diseases.

UR - http://www.scopus.com/inward/record.url?scp=84956818063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956818063&partnerID=8YFLogxK

U2 - 10.2217/9781780844176

DO - 10.2217/9781780844176

M3 - Book

AN - SCOPUS:84956818063

SN - 9781780844176

SN - 9781780844190

BT - Virus-like particles in vaccine development

PB - Future Medicine Ltd.

ER -